Theo Mantamadiotis

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 8

Top Venues

Cellular oncology (Dordrecht)

Cancer immunology, immunotherapy : CII

British journal of cancer

PLoS genetics

University of Melbourne

University of Melbourne (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Melbourne Jul 01 2011

Australia

Senior Lecturer :: Department of Microbiology & Immunology and Department of Surgery

University of Patras May 01 2009 - Jun 30 2011

Greece

Assistant Professor :: Medical School

Monash University Apr 01 2006 - Apr 01 2009

Australia

Senior Lecturer :: MIPS

Deutsches Krebsforschungszentrum May 01 1995 - Sep 01 2000

Germany

Post-doctoral fellow :: Molecular Biology of the Cell 1

Education History

University of Melbourne Mar 01 1989 - Mar 01 1993

Australia

PHD :: Ludwig Institute for Cancer Research

Monash University Mar 01 1988 - Dec 01 1988

Australia

BSC :: Biochemistry

Publications

Clarissa A Whitehead, Haoyun Fang, Huaqi Su, Andrew P Morokoff, Andrew H Kaye, Eric Hanssen, Cameron J Nowell, Katharine J Drummond, David W Greening, Laura J Vella, Theo Mantamadiotis, Stanley S Stylli
Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner. Cellular oncology (Dordrecht) (2023)
Kellie Veen, Aaron Krylov, Shuguang Yu, Jie He, Patrick Boyd, David R Hyde, Theo Mantamadiotis, Louise Y Cheng, Patricia Regina Jusuf
Her6 and Prox1a are novel regulators of photoreceptor regeneration in the zebrafish retina. PLoS genetics 19 (11) (2023)
Dylan Jones, Clarissa A Whitehead, Marija Dinevska, Samuel S Widodo, Liam M Furst, Andrew P Morokoff, Andrew H Kaye, Katharine J Drummond, Theo Mantamadiotis, Stanley S Stylli
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells. Molecular and cellular biochemistry (2022)
Marija Dinevska, Samuel S Widodo, Liam Furst, Lucero Cuzcano, Yitong Fang, Stefano Mangiola, Paul J Neeson, Phillip K Darcy, Robert G Ramsay, Ryan Hutchinson, Fabienne MacKay, Michael Christie, Stanley S Stylli, Theo Mantamadiotis
Cell signaling activation and extracellular matrix remodeling underpin glioma tumor microenvironment heterogeneity and organization. Cellular oncology (Dordrecht) (2022)
Samuel S Widodo, Ryan A Hutchinson, Yitong Fang, Stefano Mangiola, Paul J Neeson, Phillip K Darcy, Alexander D Barrow, Christopher M Hovens, Marija Dinevska, Stanley S Stylli, Theo Mantamadiotis
Toward precision immunotherapy using multiplex immunohistochemistry and in silico methods to define the tumor immune microenvironment. Cancer immunology, immunotherapy : CII 70 (7) (2021)
Samuel S Widodo, Marija Dinevska, Liam M Furst, Stanley S Stylli, Theo Mantamadiotis
IL-10 in glioma. British journal of cancer 125 (11) (2021)
Daniel V Brown, Gulay Filiz, Paul M Daniel, Frédéric Hollande, Sebastian Dworkin, Stephanie Amiridis, Nicole Kountouri, Wayne Ng, Andrew P Morokoff, Theo Mantamadiotis
Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity. PloS one 12 (2) (2017)
Paul M Daniel, Gulay Filiz, Theo Mantamadiotis
Sensitivity of GBM cells to cAMP agonist-mediated apoptosis correlates with CD44 expression and agonist resistance with MAPK signaling. Cell death & disease 7 (12) (2016)

Theo Mantamadiotis.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Theo Mantamadiotis